Holen Sie sich die Stockscreener-App
243.72
1.42%
-3.52
Handel nachbörslich:
243.72
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$247.24
Offen:
$247.82
24-Stunden-Volumen:
573.36K
Relative Volume:
0.76
Marktkapitalisierung:
$20.40B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
47.32
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
-2.36%
1M Leistung:
-6.76%
6M Leistung:
+2.16%
1J Leistung:
+13.54%
1-Tages-Spanne:
$242.80
$249.21
1-Wochen-Bereich:
$242.80
$251.84
52-Wochen-Spanne:
$205.98
$265.72
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
243.72 | 20.89B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
414.75 | 164.16B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.05 | 146.60B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
514.61 | 42.89B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.99 | 35.02B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
160.63 | 28.16B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
What analysts say about Labcorp Holdings Inc. stockFree Investment Risk Control - jammulinksnews.com
Labcorp's (NYSE:LH) Recent Rally: Is It Built on Sustainable Fundamentals or Market Hype? - AInvest
Labcorp Holdings Inc. (NYSE:LH) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo.co
Is Labcorp Holdings Inc. a good long term investmentSuperior returns - PrintWeekIndia
FTRE SECURITIES NEWS: Did Fortrea Holdings Inc. (NASDAQ:FTRE) Commit Securities Fraud? Contact BFA Law by August 1 Class Action Deadline - GlobeNewswire Inc.
Labcorp Holdings Earnings Preview: What to Expect - MSN
Labcorp Holdings Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com
What analysts say about Labcorp Holdings Inc. stock outlookHigh Return Setup Scanner - beatles.ru
Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Labcorp Holdings Inc. Set to Release Q2 Earnings Report with Strong Market PerformanceNews and Statistics - IndexBox
Will Labcorp Holdings Inc. stock benefit from AI tech trendsMarket Beating Strategy - Newser
What drives Labcorp Holdings Inc. stock priceHigh-octane investment gains - Jammu Links News
Published on: 2025-07-17 22:53:57 - Newser
My Favorite Options Trade For This Week - Benzinga
September 19th Options Now Available For Labcorp Holdings (LH) - Nasdaq
Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
What makes Labcorp Holdings Inc. stock price move sharplyFree High-Profit Stock Picks - Newser
Evercore ISI Maintains Buy Rating on Labcorp Holdings with $285 Price Target - AInvest
Why Labcorp Holdings Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser
How Labcorp Holdings Inc. stock performs during market volatilityLow Risk High Reward Picks - Newser
Hanging in the Balance: Supreme Court Declines to Decide the Uninjured Class Member Question in Labcorp v. Davis - JD Supra
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Labcorp Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72 - simplywall.st
Press Release: Labcorp Declares Quarterly Dividend - 富途牛牛
HSBC Downgrades Labcorp to Hold From Buy, $260 Price Target - MarketScreener
Labcorp Declares Quarterly Dividend, Enhancing Shareholder Value - TipRanks
Labcorp Declares Quarterly Dividend - PR Newswire
Leerink Partners Keeps Their Buy Rating on Labcorp Holdings (LH) - The Globe and Mail
Privia Health appoints former Labcorp CTO to board of directors By Investing.com - Investing.com South Africa
Privia Health appoints former Labcorp CTO to board of directors - Investing.com
Healthcare Tech Expert Joins Privia Health Board: Former Labcorp CTO to Drive Digital Innovation - Stock Titan
What Makes Labcorp (LH) a New Buy Stock - Yahoo Finance
Labcorp Holdings stock hits 52-week high at $264.04 By Investing.com - Investing.com Australia
Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low (NYSE:LH) - Seeking Alpha
LabCorp's Credit Facility Overhaul: A Playbook for Sustained Growth in Diagnostics - AInvest
Labcorp Holdings Secures $1 Billion Credit Facility - TipRanks
Labcorp Holdings Inc. (LH) Announces Upcoming Release of Q2 2025 Financial Results - GuruFocus
Labcorp to Announce Second Quarter Financial Results on July 24, 2025 - GuruFocus
Labcorp Holdings to Announce Q2 2025 Financial Results - TipRanks
Labcorp Holdings (LH) Receives Price Target Increase from Barcla - GuruFocus
Barclays Adjusts Labcorp (LH) Price Target to $275 Amid Q2 Outlook | LH Stock News - GuruFocus
Fortrea Holdings Inc. Stockholders Should Contact Robbins - GlobeNewswire
5 Insightful Analyst Questions From Labcorp’s Q1 Earnings Call - Yahoo Finance
Is Labcorp Holdings Stock Outperforming the Dow? - MSN
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? - Nasdaq
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):